216 related articles for article (PubMed ID: 35011618)
1. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
3. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
5. RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.
Bish R; Vogel C
Mol Cells; 2014 May; 37(5):357-64. PubMed ID: 24608801
[TBL] [Abstract][Full Text] [Related]
6. MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma.
Abdelfattah N; Rajamanickam S; Panneerdoss S; Timilsina S; Yadav P; Onyeagucha BC; Garcia M; Vadlamudi R; Chen Y; Brenner A; Houghton P; Rao MK
Nat Commun; 2018 Oct; 9(1):4541. PubMed ID: 30382096
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
[TBL] [Abstract][Full Text] [Related]
9. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.
de Sousa Abreu R; Sanchez-Diaz PC; Vogel C; Burns SC; Ko D; Burton TL; Vo DT; Chennasamudaram S; Le SY; Shapiro BA; Penalva LO
J Biol Chem; 2009 May; 284(18):12125-35. PubMed ID: 19258308
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells.
Whiteway SL; Harris PS; Venkataraman S; Alimova I; Birks DK; Donson AM; Foreman NK; Vibhakar R
J Neurooncol; 2013 Jan; 111(2):113-21. PubMed ID: 23138228
[TBL] [Abstract][Full Text] [Related]
12. Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma.
Harris PS; Venkataraman S; Alimova I; Birks DK; Balakrishnan I; Cristiano B; Donson AM; Dubuc AM; Taylor MD; Foreman NK; Reigan P; Vibhakar R
Mol Cancer; 2014 Mar; 13():72. PubMed ID: 24661910
[TBL] [Abstract][Full Text] [Related]
13. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).
Kanchan RK; Perumal N; Atri P; Chirravuri Venkata R; Thapa I; Klinkebiel DL; Donson AM; Perry D; Punsoni M; Talmon GA; Coulter DW; Boue' DR; Snuderl M; Nasser MW; Batra SK; Vibhakar R; Mahapatra S
Brain Pathol; 2020 Jul; 30(4):732-745. PubMed ID: 32145124
[TBL] [Abstract][Full Text] [Related]
14. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
16. A Mouse Model of Targeted Musashi1 Expression in Whole Intestinal Epithelium Suggests Regulatory Roles in Cell Cycle and Stemness.
Cambuli FM; Correa BR; Rezza A; Burns SC; Qiao M; Uren PJ; Kress E; Boussouar A; Galante PA; Penalva LO; Plateroti M
Stem Cells; 2015 Dec; 33(12):3621-34. PubMed ID: 26303183
[TBL] [Abstract][Full Text] [Related]
17. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
[TBL] [Abstract][Full Text] [Related]
18. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Forget A; Martignetti L; Puget S; Calzone L; Brabetz S; Picard D; Montagud A; Liva S; Sta A; Dingli F; Arras G; Rivera J; Loew D; Besnard A; Lacombe J; Pagès M; Varlet P; Dufour C; Yu H; Mercier AL; Indersie E; Chivet A; Leboucher S; Sieber L; Beccaria K; Gombert M; Meyer FD; Qin N; Bartl J; Chavez L; Okonechnikov K; Sharma T; Thatikonda V; Bourdeaut F; Pouponnot C; Ramaswamy V; Korshunov A; Borkhardt A; Reifenberger G; Poullet P; Taylor MD; Kool M; Pfister SM; Kawauchi D; Barillot E; Remke M; Ayrault O
Cancer Cell; 2018 Sep; 34(3):379-395.e7. PubMed ID: 30205043
[TBL] [Abstract][Full Text] [Related]
19. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.
Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF
RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
